DARE focused on disability advocacy and human rights across Europe, while EUROSHIP examined social citizenship gaps affecting people with disabilities.
Schweizer Paraplegiker-Forschung AG
Swiss rehabilitation research centre specializing in disability, workplace mental health, and social inclusion across Europe.
Their core work
Schweizer Paraplegiker-Forschung (Swiss Paraplegics Research) is a specialized research centre in Nottwil, Switzerland, focused on disability, spinal cord injury, and rehabilitation science. Their H2020 work spans disability rights and social inclusion policy, workplace mental health interventions, and the harmonization of longitudinal health cohort data. They bring a distinctive perspective that bridges clinical rehabilitation research with social science — examining how disability intersects with employment, social protection, and health across the lifecourse.
What they specialise in
EMPOWER (their largest funded project at EUR 292K) develops a platform to address depression, anxiety, stress, and absenteeism in the workplace.
SYNCHROS worked on integrating prospective cohort databases, and ATHLOS studied ageing trajectories using longitudinal health data.
Across EUROSHIP, EMPOWER, and ATHLOS, their work consistently connects health outcomes to social factors like poverty, gender, work-life balance, and social protection systems.
How they've shifted over time
Their early H2020 involvement (2015–2019) centred on disability rights, human rights law, and interdisciplinary social change — a natural extension of their core mission as a paraplegic research foundation. From 2019 onward, they shifted toward quantitative health research: cohort epidemiology, clinical trial integration, and workplace mental health interventions with measurable outcomes like cost-effectiveness and absenteeism reduction. This evolution shows a move from advocacy-oriented social research toward data-driven, applied health solutions.
SPF is moving from qualitative disability advocacy toward quantitative, intervention-based health research with clear economic outcomes — making them increasingly relevant to employers and health systems seeking evidence-based workplace solutions.
How they like to work
SPF operates exclusively as a participant, never as coordinator, which suggests they contribute specialized domain expertise — particularly around disability and rehabilitation — rather than managing large consortia. With 61 unique partners across 21 countries from just 5 projects, they consistently join large, multi-national consortia (averaging 12+ partners per project). This makes them an accessible, low-friction collaboration partner who integrates well into diverse research teams without seeking to control the agenda.
Despite only 5 projects, SPF has built a remarkably broad network of 61 partners across 21 countries, reflecting their participation in large pan-European consortia. Their reach spans most of the EU plus Switzerland, with no obvious geographic concentration beyond a general European scope.
What sets them apart
SPF occupies a rare niche at the intersection of disability/rehabilitation science and broader social and workplace health research. Unlike general public health institutes, they bring deep, lived-experience-informed understanding of disability that enriches any project examining inclusion, accessibility, or health equity. For consortium builders, they offer a credible Swiss partner with access to longitudinal patient data and a dual competence in both social policy analysis and clinical health research.
Highlights from their portfolio
- EMPOWERTheir highest-funded project (EUR 292K), developing an EU-wide workplace wellbeing platform targeting depression, anxiety, and absenteeism — their most applied and commercially relevant work.
- DAREA disability advocacy research project that directly connects to SPF's core identity, examining policy, human rights, and social change for people with disabilities across Europe.
- SYNCHROSDemonstrates SPF's methodological capacity in health data harmonization and cohort integration, positioning them for future large-scale epidemiological collaborations.